Literature DB >> 16542714

Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report.

Marie Plante1, Susie Lau, Lizabeth Brydon, Kenneth Swenerton, Richard LeBlanc, Michel Roy.   

Abstract

BACKGROUND: We present 3 young women with bulky stage IB1 cervical cancer treated with neoadjuvant chemotherapy followed by laparoscopic pelvic node dissection and vaginal radical trachelectomy. CASES: In the last year, we have treated 3 young women with large cervical lesions who wished to preserve fertility with induction chemotherapy followed by fertility-sparing surgery. They all had lesions measuring 3 to 4 cm and felt to be too big to safely undergo a radical trachelectomy. Three cycles of platinum-based combination chemotherapy were given and were well tolerated. The 3 patients had a significant clinical response to chemotherapy. A complete pathological response was confirmed by the absence of residual invasive cancer in the three trachelectomy specimens. There has been no recurrence so far and no pregnancy yet.
CONCLUSION: Neoadjuvant chemotherapy followed by a fertility-sparing surgery may become a valuable option for young women with bulky stage IB1 cervical cancer who wish to preserve their fertility potential.

Entities:  

Mesh:

Year:  2006        PMID: 16542714     DOI: 10.1016/j.ygyno.2006.02.001

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

1.  A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors.

Authors:  Pei Shu; Yali Shen; Yaqin Zhao; Feng Xu; Meng Qiu; Qiu Li; Hongfeng Gou; Dan Cao; Yu Yang; Jiyan Liu; Cheng Yi; Zhengyin Liao; Deyun Luo; Feng Bi; Xin Wang; Zhiping Li
Journal:  Med Oncol       Date:  2015-10-03       Impact factor: 3.064

Review 2.  Pharmacotherapy options for locally advanced and advanced cervical cancer.

Authors:  Alfonso Dueñas-González; Lucely Cetina; Jaime Coronel; Déborah Martínez-Baños
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

Review 3.  Conservative management of early stage cervical cancer: is there a role for less radical surgery?

Authors:  Kathleen M Schmeler; Michael Frumovitz; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2011-03       Impact factor: 5.482

Review 4.  Conservative Surgery for Early Cervical Cancer.

Authors:  P Rema; Iqbal Ahmed
Journal:  Indian J Surg Oncol       Date:  2015-10-21

Review 5.  Taxanes: their impact on gynecologic malignancy.

Authors:  Carlton L Schwab; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Anticancer Drugs       Date:  2014-05       Impact factor: 2.248

6.  Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy.

Authors:  Yulia Lakhman; Oguz Akin; Kay J Park; Debra M Sarasohn; Junting Zheng; Debra A Goldman; Michael J Sohn; Chaya S Moskowitz; Yukio Sonoda; Hedvig Hricak; Nadeem R Abu-Rustum
Journal:  Radiology       Date:  2013-06-20       Impact factor: 11.105

Review 7.  The role of trachelectomy in cervical cancer.

Authors:  Mj Halaska; H Robova; M Pluta; L Rob
Journal:  Ecancermedicalscience       Date:  2015-02-03

8.  Laparoscopic radical trachelectomy: technique, feasibility, and outcomes.

Authors:  José Martín Saadi; Myriam Perrotta; Roberto Orti; Gloria Salvo; María Eugenia Giavedoni; Sebastían Gogorza; Roberto Testa
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

9.  Fertility-sparing surgery for early-stage cervical cancer.

Authors:  Adelaide Fernanda Ribeiro Cubal; Joana Isabel Ferreira Carvalho; Maria Fernanda Martins Costa; Ana Paula Tavares Branco
Journal:  Int J Surg Oncol       Date:  2012-07-08

10.  Neoadjuvant chemotherapy followed by fertility-sparing surgery for women with stage IB1 cervical cancer.

Authors:  Dan Wang; Jiaxin Yang; Keng Shen; Yang Xiang
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.